About Evotec SE - EVO
Evotec SE is a drug discovery and development company that provides research services and develops drugs in collaboration with pharmaceutical and biotechnology firms, focusing on a variety of therapeutic areas. It employs a range of technologies and expertise in areas such as medicinal chemistry, pharmacology, and drug metabolism to support its partners and own pipeline.
What are Evotec SE's core values and mission statement?
Evotec SE's mission is to discover and develop highly effective therapeutics with an emphasis on collaboration, aiming to provide life-changing treatments for patients. Core values of the company include innovation, quality, collaboration, speed, and trust, underscored by the commitment to scientific excellence and strategic partnerships.
Who founded Evotec SE and when?
Evotec SE was founded by a group of scientists including Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Schulte, Hans SchÃ¶ler, and Rainer LÃ¶nneker in 1993.
Who leads Evotec SE?
As of my last update, Dr. Werner Lanthaler serves as the Chief Executive Officer of Evotec SE.
Where is Evotec SE located, and what is its base country?
Evotec SE is headquartered in Hamburg, Germany.
On which exchanges is Evotec SE traded?
Evotec SE is listed on the Frankfurt Stock Exchange under the ticker symbol EVT.
Evotec SE (EVO) Price Live Data
The live price of Evotec SE (EVO) is $7.40, with a trading volume of 13,499 in the last 24 hours. Wrapstocks updates the EVO price in real-time. Evotec SE is down -1.68% in the last 24 hours. The company has a live market cap of $2,622,656,256.00 and a supply of 354,413,008 EVO stocks.
Evotec SE (EVO) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 7 hours and 10 minutes.